SLC5A5 and thyroid cancer: Radioiodine treatment is usually effective in thyroid cancer patients, but it becomes ineffective when thyroid cancer cells have lost the expression of NIS and can no longer take up radioiodine as typically seen in poorly differentiated and undifferentiated thyroid cancers [7]–[10].